Abstract #1003503: A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon Ready-To-Use in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Abstract
A novel ready-to-use (RTU) liquid stable glucagon (XP-5387; Xeris Pharmaceuticals) was evaluated as treatment for symptomatic postprandial hypoglycemia after bariatric...
Paper Details
Title
Abstract #1003503: A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon Ready-To-Use in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Published Date
Jun 1, 2021
Journal
Volume
27
Issue
6
Pages
S49 - S49
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History